Market Shifts: Gene Editing Acquisition and AI Competition

This chapter delves into Eli Lilly's notable acquisition of Verve, emphasizing the premium paid on its share price. It also addresses Jabil's improved performance amid raised forecasts and previews a discussion on Amazon Web Services' chip technology poised to rival NVIDIA in the AI sector.